Acute phase reaction to gadolinium-DTPA in dialysis patients

Nephrology Dialysis Transplantation

Volumn 24, Issue 4, 2009, Pages 1274-1277

  Steen, Henning ^a   Giannitsis, Evangelos ^a   Sommerer, Claudia ^b   Bahner, Udo ^c   Brandl, Margit ^c   Merbach, Christoph ^a   Merten, Constanze ^a   Ritz, Eberhard ^b   Katus, Hugo A ^a   Zeier, Martin ^b   Schwenger, Vedat ^b  

^a Department of Internal Medicine

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Kfh Nierenzentrum Würzburg ^*  (Germany)

Author keywords

Acute phase reaction; Acute renal failure; Dialysis; Gadolinium; Keywords; Lymphopenia

Indexed keywords

C REACTIVE PROTEIN; GADOLINIUM PENTETATE; STEROID;

ACUTE PHASE RESPONSE; ADULT; AGED; ANURIA; ARTICLE; BACTERIUM CONTAMINATION; BLOOD CULTURE; BLOOD FLOW; BLOOD PRESSURE MONITORING; CHEMOTHERAPY INDUCED EMESIS; CHILL; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE COURSE; DIURESIS; DRUG EFFECT; DRUG FEVER; DYSPNEA; EOSINOPHIL; FEMALE; HEART RATE; HEMODIALYSIS PATIENT; HUMAN; INDUCED HYPOTENSION; LEUKOCYTE COUNT; LYMPHOCYTOPENIA; MALAISE; MALE; NAUSEA; NEUTROPHIL; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POLYURIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTICEMIA; SHIVERING; SIDE EFFECT; SKIN MANIFESTATION;

ACUTE-PHASE REACTION; AGED; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 65349084592     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn655     Document Type: Article

References (15)

1. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006; 21: 1104-1108
2. Broome DR. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Eur J Radiol 2008; 66: 208-212
3. Saab G, Abu-Alfa A. Nephrogenic systemic fibrosis-implications for nephrologists. Eur J Radiol 2008; 66: 208-212
4. Shabana WM, Cohan RH, Ellis JH et al. Nephrogenic systemic fibrosis: a report of 29 cases. AJR Am J Roentgenol 2008; 190: 736- 741
5. LeBoit PE. What nephrogenic fibrosing dermopathy might be. Arch Dermatol 2003; 139: 928-930
6. Gemery J, Idelson B, Reid S et al. Acute renal failure after arteriography with a gadolinium-based contrast agent. AJR Am J Roentgenol1998; 171: 1277-1278
7. Wiginton CD, Kelly B, Oto A et al. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. AJR Am J Roentgenol 2008; 190: 1060-1068
8. Nelson KL, Gifford LM, Lauber-Huber C et al. Clinical safety of gadopentetate dimeglumine. Radiology 1995; 196: 439-443
9. Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br JRadiol 2003; 76: 513-518
10. Rosenthal DI, Becerra CR, Toto RD et al. Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin. Am J Clin Oncol 2000; 23: 593-598
11. Hardonk MJ, Dijkhuis FW, Hulstaert CE et al. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol 1992; 52: 296-302
12. Sehic E, Li S, Ungar AL et al. Complement reduction impairs the febrile response of guinea pigs to endotoxin. Am J Physiol 1998; 274: R1594-R1603
13. Rai RM, Zhang JX, Clemens MG et al. Gadolinium chloride alters the acinar distribution of phagocytosis and balance between pro-and anti-inflammatory cytokines. Shock 1996; 6: 243- 247
14. Niebauer J,Volk HD,KempMet al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999; 353: 1838-1842
15. Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypothesis. Lancet 2000; 356: 930-933